跳至主要内容
临床试验/NL-OMON22349
NL-OMON22349已完成不适用

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells in patients with advanced limb ischemia.

eiden University Medical Center.0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

J Cardiovasc Surg (Torino). 2008 Feb;49(1):51-8.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Disabling claudication (Fontaine’s stages IIb/III or Rutherford’s categories 3/4) or critical limb ischemia (Fontaine’s stages IV or Rutherford’s categories 5/6) despite > 6 months optimal medical therapy;
  • 2. Ineligibility for angioplasty or bypass procedures;

排除标准

  • 1. Candidates for angioplasty or bypass procedures;
  • 2. Inability to undergo bone marrow harvesting;

研究者

发起方
eiden University Medical Center.

相似试验